Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
GSK's ADC Blenrep delivers survival win against J&J's Darzalex
The head-to-head overall survival win makes GSK’s £3 billion peak sales goal for the multiple myeloma antibody-drug conjugate look more attainable.
Angus Liu
Nov 14, 2024 9:24am
GSK takes aim at challenges facing gynecological cancer patients
Nov 12, 2024 8:00am
GSK breaks up with BIO for 2025
Nov 8, 2024 4:51pm
Amgen, AZ's Tezspire excels in phase 3 rhinosinusitis trial
Nov 8, 2024 3:31pm
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
Nov 1, 2024 8:20am
GSK's RSV vaccine sales plummet in wake of guidance changes
Oct 30, 2024 10:41am
